Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 17, 2025Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition

Clinical Utility of the PI-RADSv2.1 Combined with PSA Parmeters for Prostate Biopsy Indication

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYuchun LiYZYunfu ZengSWSiran Wang

Discussion

Loading...

Member takes

Overview

Retrospective analysis identified key risks in prostate cancer, suggesting combined use of pi-rads and psa enhances diagnostic precision.

Key Points

  • Combining PI-RADS v2.1 scores with PSAD reduced unnecessary prostate biopsies by 40%.
  • The analysis showed an area under the curve (AUC) of 0.964 for the combined diagnostic method.
  • Logistic regression identified PI-RADS v2.1 score and PSAD as independent risk factors for clinically significant prostate cancer.
  • This integrated approach enhances patient care by allowing safe avoidance of biopsies in certain cases.

Cite This Study

Li et al. (2025) studied this question.

synapsesocial.com/papers/68d45b0b31b076d99fa5d2bfhttps://doi.org/10.58530/2025/2811
View Full Paper
Ask AI
Bookmark
Share